182 related articles for article (PubMed ID: 27552247)
1. Nonnuclear Estrogen Receptor Activation Improves Hepatic Steatosis in Female Mice.
Chambliss KL; Barrera J; Umetani M; Umetani J; Kim SH; Madak-Erdogan Z; Huang L; Katzenellenbogen BS; Katzenellenbogen JA; Mineo C; Shaul PW
Endocrinology; 2016 Oct; 157(10):3731-3741. PubMed ID: 27552247
[TBL] [Abstract][Full Text] [Related]
2. Bazedoxifene and conjugated estrogen prevent diet-induced obesity, hepatic steatosis, and type 2 diabetes in mice without impacting the reproductive tract.
Barrera J; Chambliss KL; Ahmed M; Tanigaki K; Thompson B; McDonald JG; Mineo C; Shaul PW
Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E345-54. PubMed ID: 24939737
[TBL] [Abstract][Full Text] [Related]
3. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance.
Zhu L; Brown WC; Cai Q; Krust A; Chambon P; McGuinness OP; Stafford JM
Diabetes; 2013 Feb; 62(2):424-34. PubMed ID: 22966069
[TBL] [Abstract][Full Text] [Related]
4. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
5. Chronic angiotensin AT2R activation prevents high-fat diet-induced adiposity and obesity in female mice independent of estrogen.
Nag S; Khan MA; Samuel P; Ali Q; Hussain T
Metabolism; 2015 Jul; 64(7):814-25. PubMed ID: 25869303
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the liver lipidome reveals insights into the protective effect of exercise on high-fat diet-induced hepatosteatosis in mice.
Jordy AB; Kraakman MJ; Gardner T; Estevez E; Kammoun HL; Weir JM; Kiens B; Meikle PJ; Febbraio MA; Henstridge DC
Am J Physiol Endocrinol Metab; 2015 May; 308(9):E778-91. PubMed ID: 25714675
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
8. Selective Activation of Estrogen Receptor α Activation Function-1 Is Sufficient to Prevent Obesity, Steatosis, and Insulin Resistance in Mouse.
Guillaume M; Handgraaf S; Fabre A; Raymond-Letron I; Riant E; Montagner A; Vinel A; Buscato M; Smirnova N; Fontaine C; Guillou H; Arnal JF; Gourdy P
Am J Pathol; 2017 Jun; 187(6):1273-1287. PubMed ID: 28502695
[TBL] [Abstract][Full Text] [Related]
9. Changes in adiponectin and inflammatory genes in response to hormonal imbalances in female mice and exacerbation of depot selective visceral adiposity by high-fat diet: implications for insulin resistance.
Zhang H; Chen X; Aravindakshan J; Sairam MR
Endocrinology; 2007 Dec; 148(12):5667-79. PubMed ID: 17717050
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice.
Cho SJ; Jung UJ; Choi MS
Br J Nutr; 2012 Dec; 108(12):2166-75. PubMed ID: 22414733
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.
Ushio M; Nishio Y; Sekine O; Nagai Y; Maeno Y; Ugi S; Yoshizaki T; Morino K; Kume S; Kashiwagi A; Maegawa H
Am J Physiol Endocrinol Metab; 2013 Jul; 305(2):E293-304. PubMed ID: 23715726
[TBL] [Abstract][Full Text] [Related]
12. Spironolactone improves glucose and lipid metabolism by ameliorating hepatic steatosis and inflammation and suppressing enhanced gluconeogenesis induced by high-fat and high-fructose diet.
Wada T; Kenmochi H; Miyashita Y; Sasaki M; Ojima M; Sasahara M; Koya D; Tsuneki H; Sasaoka T
Endocrinology; 2010 May; 151(5):2040-9. PubMed ID: 20211973
[TBL] [Abstract][Full Text] [Related]
13. Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function.
Valdecantos MP; Pérez-Matute P; González-Muniesa P; Prieto-Hontoria PL; Moreno-Aliaga MJ; Martínez JA
J Nutr Biochem; 2012 Dec; 23(12):1676-84. PubMed ID: 22464149
[TBL] [Abstract][Full Text] [Related]
14. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice.
Newberry EP; Xie Y; Kennedy SM; Luo J; Davidson NO
Hepatology; 2006 Nov; 44(5):1191-205. PubMed ID: 17058218
[TBL] [Abstract][Full Text] [Related]
15. The androgen receptor confers protection against diet-induced atherosclerosis, obesity, and dyslipidemia in female mice.
Fagman JB; Wilhelmson AS; Motta BM; Pirazzi C; Alexanderson C; De Gendt K; Verhoeven G; Holmäng A; Anesten F; Jansson JO; Levin M; Borén J; Ohlsson C; Krettek A; Romeo S; Tivesten Å
FASEB J; 2015 Apr; 29(4):1540-50. PubMed ID: 25550469
[TBL] [Abstract][Full Text] [Related]
16. High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids.
Garcia Caraballo SC; Comhair TM; Houten SM; Dejong CH; Lamers WH; Koehler SE
J Nutr Biochem; 2014 Dec; 25(12):1263-74. PubMed ID: 25287814
[TBL] [Abstract][Full Text] [Related]
17. Reversion of steatosis by SREBP-1c antisense oligonucleotide did not improve hepatic insulin action in diet-induced obesity mice.
Vitto MF; Luz G; Luciano TF; Marques SO; Souza DR; Pinho RA; Lira FS; Cintra DE; De Souza CT
Horm Metab Res; 2012 Nov; 44(12):885-90. PubMed ID: 22932913
[TBL] [Abstract][Full Text] [Related]
18. Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets.
Zuo Q; Chen KL; Arredondo Eve A; Liu YJ; Kim SH; Katzenellenbogen BS; Katzenellenbogen JA; Madak-Erdogan Z
Nutrients; 2021 Sep; 13(10):. PubMed ID: 34684335
[TBL] [Abstract][Full Text] [Related]
19. Rhein ameliorates fatty liver disease through negative energy balance, hepatic lipogenic regulation, and immunomodulation in diet-induced obese mice.
Sheng X; Wang M; Lu M; Xi B; Sheng H; Zang YQ
Am J Physiol Endocrinol Metab; 2011 May; 300(5):E886-93. PubMed ID: 21364120
[TBL] [Abstract][Full Text] [Related]
20. C-C chemokine receptor 2 inhibitor ameliorates hepatic steatosis by improving ER stress and inflammation in a type 2 diabetic mouse model.
Kim HM; Lee ES; Lee BR; Yadav D; Kim YM; Ko HJ; Park KS; Lee EY; Chung CH
PLoS One; 2015; 10(3):e0120711. PubMed ID: 25816097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
